Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hettel

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Urology Practice|May 5, 2023
IsoPSA<sup>®</sup> Reduces Provider Recommendations for Biopsy and Magnetic Resonance Imaging in Men with Total Prostate Specific Antigen ≥4 ng/ml: A Real-World Observational Clinical Utility StudyJason M Scovell, Daniel Hettel, Robert Abouassaly, et al.
Urology|May 10, 2019
Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active SurveillanceCharles Dai, Vishnu Ganesan, Yaw A Nyame, et al.
Neurourology and Urodynamics|May 29, 2024
Sacral neuromodulation device biofilm differs in the absence and presence of infection, harbors antibiotic resistance genes, and is reproducible in vitroGlenn T Werneburg, Daniel Hettel, Ava Adler, et al.
Biomedicines|January 21, 2023
Biofilms on Indwelling Artificial Urinary Sphincter Devices Harbor Complex Microbe-Metabolite Interaction Networks and Reconstitute Differentially In Vitro by Material TypeGlenn T Werneburg, Daniel Hettel, Ava Adler, et al.
Urology|June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active SurveillanceVishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
The Journal of Urology|August 10, 2017
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable FeaturesCharles Dai, Vishnu Ganesan, Joseph Zabell, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Urology Practice|May 5, 2023
IsoPSA<sup>®</sup> Reduces Provider Recommendations for Biopsy and Magnetic Resonance Imaging in Men with Total Prostate Specific Antigen ≥4 ng/ml: A Real-World Observational Clinical Utility StudyJason M Scovell, Daniel Hettel, Robert Abouassaly, et al.
Urology|May 10, 2019
Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active SurveillanceCharles Dai, Vishnu Ganesan, Yaw A Nyame, et al.
Neurourology and Urodynamics|May 29, 2024
Sacral neuromodulation device biofilm differs in the absence and presence of infection, harbors antibiotic resistance genes, and is reproducible in vitroGlenn T Werneburg, Daniel Hettel, Ava Adler, et al.
Biomedicines|January 21, 2023
Biofilms on Indwelling Artificial Urinary Sphincter Devices Harbor Complex Microbe-Metabolite Interaction Networks and Reconstitute Differentially In Vitro by Material TypeGlenn T Werneburg, Daniel Hettel, Ava Adler, et al.
Urology|June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active SurveillanceVishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
The Journal of Urology|August 10, 2017
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable FeaturesCharles Dai, Vishnu Ganesan, Joseph Zabell, et al.
Pageof 2